iBio Inc. stock falls Wednesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock outperforms market despite losses on the day | news.google.com • |
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | -0.46 | N/A | N/A | N/A |
2024-05-13 | 2024-03 | 0 | -0.71 | N/A | N/A |
2024-02-09 | 2023-12 | 0 | -2.42 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -4.2 | N/A | N/A |
2023-10-10 | 2023-06 | 0 | N/A | N/A | N/A |
2023-07-06 | 2023-03 | 0 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-31 | BRENNER MARTIN | Chief Executive Officer | 182.50K | Sale |
2014-09-16 | DESANTIS CARL R | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-03-30 | DURAN FELIPE | Chief Financial Officer | 39.63K | Stock Award(Grant) |
2020-08-10 | EASTERN CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2020-06-03 | ERWIN ROBERT L | President | 108.11K | Sale |
2020-03-18 | ISETT THOMAS FRANCIS III | Chief Executive Officer | 1.27M | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 512.28K | 312.49K | 1.86% |
2023-06-29 | Avantax Planning Partners, Inc. | 155.00K | 94.55K | 0.56% |
2023-06-29 | Blackrock Inc. | 137.94K | 84.14K | 0.50% |
2023-06-29 | Bank Of New York Mellon Corporation | 87.47K | 53.36K | 0.32% |
2023-06-29 | Geode Capital Management, LLC | 76.29K | 46.53K | 0.28% |
2023-06-29 | Renaissance Technologies, LLC | 46.10K | 28.12K | 0.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 336.21K | 205.09K | 1.22% |
2023-06-29 | Vanguard Extended Market Index Fund | 165.75K | 101.11K | 0.60% |
2023-05-30 | Fidelity Extended Market Index Fund | 46.85K | 32.80K | 0.17% |
2023-05-30 | Fidelity Total Market Index Fund | 13.73K | 9.61K | 0.05% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.49K | 6.64K | 0.03% |
2023-06-29 | Vanguard Institutional Index-Inst Total Stock Market Ind | 7.28K | 4.44K | 0.03% |
Split | Date |
---|---|
1 : 20 | 2023-11-29 |
1 : 25 | 2022-10-10 |
1 : 10 | 2018-06-11 |
-
-
-
-
I don’t understand the Bears, why they are so hesitant of buying this. It’s very very cheap. I already have enough but I will load more tomorrow at pre Market.
You need to thank the Bulls here for pushing you. Lol. Like Thursday we told ya to hold but some didn’t listen. Now it’s a little bit higher but still plenty of room to load. We’ll see. If goes down that’s fine it’s an opportunity to load again. Eventually this will rise because of the volume and the status the COVID19 raise. Whoever gets to the top is the winner, once we have the winner than that’s it we have to stop applause the winner!
-
-
Lesson learned: I will never do the same mistakes again I did with KBIO (2015), MRNA (2020) and NVAX (2020). Long is the answer! Higher risk but better reward!!!
-
I am carving my money from MRNA, INO, NVAX and BNTX moving it to IBIO and EQ.
This will be a lot FUN tomorrow!!! So excited... I will blend coffee in the morning and will be watching closely on these 2 heavy Favorites stocks.
-
Last Friday IBIO’s flew only from College Station to nearby Houston’s NASA to be on-board for the Rocket launch this week to MARS. This instruction came from the New York HQ and said final destination is PLUTO... they only stop over in MARS for refueling!
-
Sold 131,500 shares at $1.92....just want to kill myself!!!
-
My memory still fresh about KBIO where I sold Friday and then over weekend it rallied where I should be a Millionaire by now if I gambled and have patience.
Another is NVAX where I sold at 30
Early was MRNA at 48Well, I still have a very good gain this year and IRS was happy as well last year for the TAX they earned from me. This year they will smile even more!!!
-
If there’s a company out there need to be approved for the Vaccine and if IBIO is ready then it will be No Brainer.
-
I’m just trying to pay for my in ground irrigation system for my front yard haha I hope we see 15$ within the next week or two!! Lets go!
-
-
-
-
IBIO will be like INO, NVAX and MRNA soon.
-
The 1 Coronavirus Stock I’d Buy Right Now
This company’s shares will climb if it wins the coronavirus vaccine race. If it doesn’t, gains still may be on the horizon.
Adria Cimino
Clinical-stage biotech companies including Moderna (NASDAQ:MRNA) and Inovio Pharmaceuticals (NASDAQ:INO) have been scoring big gains as investors bet on their COVID-19 vaccine candidates. These companies' shares have soared by 228% and 717%, respectively, in the first half of 2020. The idea of buying into that kind of performance is tempting, but the big risk is this: Clinical-stage companies don't yet have products on the market, so if their COVID-19 efforts fail, there isn't another immediate chance for revenue. -
If you want to be a Millionaire go for LONG on this one until it hits a 100$ like NVAX and MRNA... I have those 2 playing in and out where I got a good gain but those were so little if stick to my plan and didn’t sell it. I am not going to do the same mistake on IBIO and EQ. I will risk all the way down for a better reward!!!
-
iBio Inc. stock falls Wednesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock outperforms market despite losses on the day
news.google.com • -
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update
news.google.com • -
iBio Inc. stock rises Friday, outperforms market
news.google.com • -
iBio Inc. stock rises Thursday, still underperforms market
news.google.com •